Loading clinical trials...
Loading clinical trials...
Vaginal delivery may cause various levels of damage to the anal sphincter. According to the literature, one third - two third of women diagnosed with 3rd degree rupture during vaginal delivery suffer from fecal incontinence. This has an adverse effect on the quality of life. Different risk factors such as: first births, instrumental delivery, high birth weight, prolonged second stage, epidural anesthesia etc. were assessed and found to be associated with anal sphincter disruption. The purpose of this study is to assess risk factors for anal sphincter disruption by new methods such as three-Dimensional transperineal ultrasound (3D transperineal US).
Age
17 - 42 years
Sex
FEMALE
Healthy Volunteers
Yes
Hadassah Medical Organization
Jerusalem, Israel
Start Date
March 1, 2011
Primary Completion Date
March 1, 2014
Completion Date
March 1, 2014
Last Updated
July 28, 2015
33
ACTUAL participants
3D transperineal Ultrasound
OTHER
Lead Sponsor
Hadassah Medical Organization
NCT05626816
NCT06532123
NCT05530681
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions